December 16, 2011
1 min read
Save

Disease recurrence may affect cataract surgery outcomes in Vogt-Koyanagi-Harada patients


Br J Ophthalmol. 2011;95(11):1542-1546.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients with Vogt-Koyanagi-Harada disease can experience positive outcomes from cataract surgery, but there is a risk of disease recurrence, according to a study.

The retrospective analysis examined 105 Vogt-Koyanagi-Harada patients, 28 of whom had cataract surgery on 50 eyes.

At 3 months postop, 41 eyes improved by at least two Snellen lines. Visual acuity stabilized in 43 eyes by 6 months postop; there was no difference in best corrected visual acuity between 6 months and 12 months postop.

BCVA improved by two or more Snellen lines in six eyes between 6 months and 12 months postop, while one eye experienced a reduction of two or more Snellen lines in that period.

The study also found 21 eyes experienced postop recurrences.

"Cataract surgery in [Vogt-Koyanagi-Harada] eyes was safe and resulted in improved [visual acuity] in 80% of eyes," the study authors wrote. "The main risk factor for poor outcome following cataract surgery was disease recurrence. Pre-existing posterior pole abnormalities also limited the visual improvement that could be achieved."

The study was limited by small sample size, lack of a control group, its retrospective nature and non-standardized treatment protocols, the authors said.